1 |
Tada H, Wallace SJ, Hughes IA. Height in epilepsy. Arch Dis Child 1986;61:1224-6
DOI
|
2 |
Kliegman RM, Behrman RE, Jenson HB, Stanton BF. Nelson textbook of pediatrics. 18th ed. Saunders Co, 2007:33-4
|
3 |
Macardle BM., Mcgowan ME, Greene SA, Miller CS. Anticonversant drugs, growth, and development. Arch Dis child 1987;62:615-7
DOI
|
4 |
Volpe SL, Schall JI, Gallagher PR, Stallings VA, Bergqvist AGC. Nutrient intake of Children with intractable epilepsy compared with healthy children. J Am Diet Assoc 2007;107: 1014-18
DOI
ScienceOn
|
5 |
Vries LD, Karasik A, Landau Z, Phillip M, Kiviti S, Goldberg-Stern H. Endocrine effects of valproate in adolescent girls with epilepsy. Epilepsia 2007;48:470-7
DOI
ScienceOn
|
6 |
Novak GP, Maytal J, Alshansky A. Risk of excessive weight gain in epileptic children treated with valproate, J Child Neurol 1999;14:490-5
DOI
|
7 |
McEwan MJ, Espie CA, Metcalfe J, Brodie MJ, Wilson MT. Quality of life and psychosocial development in adolescents with epilepsy: A qualitative investigation using focus group methods. Seizure 2004;13:15-31
DOI
ScienceOn
|
8 |
Wu S, Legido A, De Luca F. Effects of valproic acid on longitudinal bone growth. J Child Neurol 2004;19:26-30
DOI
|
9 |
Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59:205-10
DOI
ScienceOn
|
10 |
Hauser WA. Epilepsy Frequency, Causes and Consequences. NewYork, NY: Demos;1990
|
11 |
El-Khayat HA, Abd El-Basset FZ, Tomoum HY, Tohamy SM, Zaky AA, Mohamed MS et al. Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. Epilepsia 2004;45:1106-15
DOI
ScienceOn
|
12 |
Ueberall MA, Normal growth during lamotrigine monotherapy in pediatric epilepsy patients. Epilepsy 2001;46:63-7
DOI
ScienceOn
|
13 |
Hanai T. Quality of life in children with epilepsy. Epilepsia 1996;37(suppl 3):28-32
DOI
ScienceOn
|
14 |
Baer MT, Kozlowski BW, Blyler EM, Trahms CM, Taylor ML, Hogan MP. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr 1997;65:1042-51
DOI
|
15 |
Bertoli S, Cardinali S, Veggiotti P, Trentani C, Testolin G, Tagliabue A. Evaluation of nutritional status in children with refractory epilepsy. Nutritional Journal 2006;5-14
|
16 |
Camfield PR, Camfield CS. Antiepileptic drug therapy. When is epilepsy truly intractable? Epilepsia 1996;37(suppl 1):S60-65
DOI
ScienceOn
|
17 |
Trier E, Tomas AG. Feeding the disabled child. Nutrition 1998;14:810-5
|
18 |
McEwan MJ, Espie CA, Metcalfe J. A systematic review of the contribution of qualitative research to the study of quality of life in children and adolescents with epilepsy. Seizure 2004;13:3-14
DOI
ScienceOn
|
19 |
Mikkonen K, Knip M, Pakarinen AJ, Lanning P, Isojärvi JI, Vainionpää LK. Growth and lipid metabolism in girls and young women with eilepsy during pubertal maturation. Epilepsia 2005;46:1114-20
DOI
ScienceOn
|
20 |
El-Khayat HA, Shatlah HM, Ali GK, Adbulgani MO, Tomoum HY, Attya HA. Physical and hormonal profile of male sexual development in epilepsy. Epilepsia 2003;44:447- 52
DOI
ScienceOn
|
21 |
Guo CY, Ronen GM, Atkinson SA. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Eilepsia 2001; 42:1141-7
DOI
ScienceOn
|
22 |
Dahlin MG, Ohman IK, Age and antiepileptic drugs influece topiramate plasma levels in children. Pediatr Neurol 2004; 31:248-53
DOI
ScienceOn
|